Latest news

Thumbnail image for Six new medicines backed for EU approval

Six new medicines backed for EU approval

Six new medicines, including three orphan drugs for rare diseases, have been backed for European Union approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

27th March 2017

Thumbnail image for Pfizer bags approval for RA drug Xeljanz

Pfizer bags approval for RA drug Xeljanz

Some patients with moderate to severe forms of rheumatoid arthritis could get access to a new treatment option in Europe following the approval of Pfizer’s oral Janus kinase (JAK) inhibitor Xeljanz.

27th March 2017

Thumbnail image for Shire’s rare blood disorder drug gets US fast track

Shire’s rare blood disorder drug gets US fast track

An experimental therapy in development by Shire for patients with the rare blood disorder hereditary thrombotic thrombocytopenic purpura (hTTP) has been granted a fast track designation by the US Food and Drug Administration.

23rd March 2017

Thumbnail image for Three-quarters of CCGs failing to improve child mental health

Three-quarters of CCGs failing to improve child mental health

Almost three-quarters (73.2 percent) of local Clinical Commissioning Groups are failing to meet NHS England targets for improving children and young people’s mental health services (CAMHS), shows a new analysis by the Education Policy Institute.

23rd March 2017

Thumbnail image for NHS trusts under growing pressure to make savings

NHS trusts under growing pressure to make savings

Trusts are grappling with growing pressure from the top to increase savings in the approaching financial year, a survey by NHS Providers has revealed, just as three more are placed in financial special measures by the Care Quality Commission.

23rd March 2017

Thumbnail image for NICE backs use of drugs for breast cancer prevention

NICE backs use of drugs for breast cancer prevention

The National Institute for Health and Care Excellence has now published updated familial breast cancer guidelines which advocate the use of three medicines to reduce the risk of developing the disease.

23rd March 2017

Thumbnail image for Contraceptive pill reduces cancer risk long-term, study finds

Contraceptive pill reduces cancer risk long-term, study finds

Women who have taken the oral contraceptives seem have a reduced risk of developing some types of cancer for as long as thirty years, suggests new research from The University of Aberdeen, published in the American Journal of Obstetrics and Gynaecology.

22nd March 2017

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download